Lichtenberg-Kraag B, Mandelkow E M, Biernat J, Steiner B, Schröter C, Gustke N, Meyer H E, Mandelkow E
Max-Planck-Unit for Structural Molecular Biology, DESY, Hamburg, Federal Republic of Germany.
Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5384-8. doi: 10.1073/pnas.89.12.5384.
We have studied the phosphorylation of tau protein from Alzheimer paired helical filaments, of tau from normal human brain, and of recombinant tau isoforms. As a tool we used monoclonal antibodies against neurofilament protein [Sternberger, N., Sternberger, L. & Ulrich, J. (1985) Proc. Natl. Acad. Sci. USA 82, 4274-4276] that crossreact with tau in a phosphorylation-dependent manner. This allowed us to deduce the state of phosphorylation in normal and pathological tau, as well as antibody epitopes. The epitope of antibody SMI33 is at the first Lys-Ser-Pro sequence motif (residues 234-236) and requires an unphosphorylated Ser-235. Antibody SMI31 binds between Ser-396 (in the second Lys-Ser-Pro motif) and Ser-404, both of which must be phosphorylated. SMI34 has a conformational epitope that depends on the interaction between regions on either side of the microtubule-binding region; it also requires phosphorylation. The phosphorylatable serines detected by the SMI antibodies are part of Ser-Pro motifs and can be phosphorylated by a protein kinase activity that can be used to induce a paired helical filament-like state in human brain tau in vitro. The phosphates are incorporated in several stages that can be identified by antibody reactivity and gel shift. This suggests a role for the phosphorylation sites in Alzheimer disease, as well as the involvement of a Ser-Pro-directed protein kinase.
我们研究了来自阿尔茨海默病配对螺旋丝的tau蛋白、正常人脑tau蛋白以及重组tau异构体的磷酸化情况。作为一种工具,我们使用了针对神经丝蛋白的单克隆抗体[Sternberger, N., Sternberger, L. & Ulrich, J. (1985) Proc. Natl. Acad. Sci. USA 82, 4274 - 4276],该抗体以磷酸化依赖的方式与tau发生交叉反应。这使我们能够推断正常和病理性tau的磷酸化状态以及抗体表位。抗体SMI33的表位位于第一个Lys - Ser - Pro序列基序(残基234 - 236)处,且需要未磷酸化的Ser - 235。抗体SMI31结合在Ser - 396(位于第二个Lys - Ser - Pro基序中)和Ser - 404之间,这两个位点都必须被磷酸化。SMI34具有一个构象表位,该表位依赖于微管结合区域两侧区域之间的相互作用;它也需要磷酸化。SMI抗体检测到的可磷酸化丝氨酸是Ser - Pro基序的一部分,并且可以被一种蛋白激酶活性磷酸化,该蛋白激酶活性可用于在体外诱导人脑海tau形成配对螺旋丝样状态。磷酸盐在几个阶段被掺入,这些阶段可以通过抗体反应性和凝胶迁移来识别。这表明磷酸化位点在阿尔茨海默病中发挥作用,以及一种Ser - Pro定向蛋白激酶的参与。